These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8675167)
21. Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506). Chen YW; Smith ML; Sheets MP; Ballaron SJ; Trevillyan JM; Fey TA; Gauvin DM; Kolano R; Pong MS; Hsieh GC; Bauch J; Marsh K; Carter G; Luly J; Djuric S; Mollison KW Clin Immunol; 1999 Jan; 90(1):133-40. PubMed ID: 9884362 [TBL] [Abstract][Full Text] [Related]
22. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253 [TBL] [Abstract][Full Text] [Related]
23. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249 [TBL] [Abstract][Full Text] [Related]
24. CD4-veCD8-ve CD30+ve T cells are detectable in human lung transplant patients and their proportion of the lymphocyte population after in vitro stimulation with donor spleen cells correlates with preservation of lung physiology. Polster K; Walker A; Fildes J; Entwistle G; Yonan N; Hutchinson IV; Leonard CT Transplant Proc; 2005 Jun; 37(5):2257-60. PubMed ID: 15964393 [TBL] [Abstract][Full Text] [Related]
25. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation. Sakagawa T; Kiyochi H; Honda K; Kobayashi N Transpl Immunol; 2004 Nov; 13(3):161-8. PubMed ID: 15381198 [TBL] [Abstract][Full Text] [Related]
27. Analysis of KIR2D receptors on peripheral blood lymphocytes from liver graft recipients. López-Alvarez MR; Gómez-Mateo J; Ruiz-Merino G; Campillo JA; Miras M; García-Alonso AM; Sánchez-Bueno F; Parrilla P; Alvarez-López MR; Minguela A Transpl Immunol; 2006 Dec; 17(1):51-4. PubMed ID: 17157216 [TBL] [Abstract][Full Text] [Related]
28. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection. Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772 [TBL] [Abstract][Full Text] [Related]
30. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Ueki S; Yamashita K; Aoyagi T; Haga S; Suzuki T; Itoh T; Taniguchi M; Shimamura T; Furukawa H; Ozaki M; Umezawa K; Todo S Transplantation; 2006 Dec; 82(12):1720-7. PubMed ID: 17198266 [TBL] [Abstract][Full Text] [Related]
31. [FK506 and kifunensine, new immunomodulators of microbial origin]. Izumi S; Okuhara M Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1800-12. PubMed ID: 7692469 [No Abstract] [Full Text] [Related]
32. [Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients]. Bai YJ; Wang LL; Cai B; Zou YG; Feng WH; Yan LN Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):989-92. PubMed ID: 18845086 [TBL] [Abstract][Full Text] [Related]
33. Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. Koprak S; Sirotina A; Ok H; Dumont FJ Transplantation; 1996 Mar; 61(6):926-32. PubMed ID: 8623162 [TBL] [Abstract][Full Text] [Related]
34. FK506: inhibition of humoral mechanisms of hepatic allograft rejection. Woodle ES; Perdrizet GA; Brunt EM; So SK; Jendrisak MD; McCullough CS; Vehe KL; White HM; Peters MG; Mohanakumar T Transplantation; 1992 Aug; 54(2):377-81. PubMed ID: 1379749 [No Abstract] [Full Text] [Related]
35. The detection and evaluation of migration stimulatory factor in renal allograft recipients. Cerilli J; Fesperman DP Surgery; 1976 Jul; 80(1):92-7. PubMed ID: 775669 [TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation. Spangrude GJ; Braaten BA; Daynes RA J Immunol; 1984 Jan; 132(1):354-62. PubMed ID: 6537815 [TBL] [Abstract][Full Text] [Related]
37. Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection. Wang JD; Nonomura N; Takahara S; Li BS; Azuma H; Ichimaru N; Kokado Y; Matsumiya K; Miki T; Suzuki S; Okuyama A Immunology; 1998 Sep; 95(1):56-61. PubMed ID: 9767457 [TBL] [Abstract][Full Text] [Related]
38. [Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. Tanaka H; Nakahara K; Hatanaka H; Inamura N; Kuroda A Yakugaku Zasshi; 1997 Aug; 117(8):542-54. PubMed ID: 9306728 [TBL] [Abstract][Full Text] [Related]
39. Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus. Maguire O; Tornatore KM; O'Loughlin KL; Venuto RC; Minderman H Cytometry A; 2013 Dec; 83(12):1096-104. PubMed ID: 24136923 [TBL] [Abstract][Full Text] [Related]